Legal & General Group’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $142K | Sell |
18,858
-23,950
| -56% | -$180K | ﹤0.01% | 2611 |
|
|
2025
Q1 | $324K | Hold |
42,808
| – | – | ﹤0.01% | 2528 |
|
|
2024
Q4 | $521K | Buy |
42,808
+1,315
| +3% | +$16K | ﹤0.01% | 2442 |
|
|
2024
Q3 | $695K | Buy |
41,493
+2,242
| +6% | +$37.5K | ﹤0.01% | 2355 |
|
|
2024
Q2 | $685K | Buy |
39,251
+19,690
| +101% | +$343K | ﹤0.01% | 2317 |
|
|
2024
Q1 | $333K | Buy |
19,561
+5,552
| +40% | +$94.6K | ﹤0.01% | 2577 |
|
|
2023
Q4 | $143K | Hold |
14,009
| – | – | ﹤0.01% | 2739 |
|
|
2023
Q3 | $127K | Sell |
14,009
-562
| -4% | -$5.09K | ﹤0.01% | 2801 |
|
|
2023
Q2 | $157K | Buy |
14,571
+7,921
| +119% | +$85.2K | ﹤0.01% | 2791 |
|
|
2023
Q1 | $68K | Buy |
6,650
+635
| +11% | +$6.5K | ﹤0.01% | 2831 |
|
|
2022
Q4 | $63.5K | Hold |
6,015
| – | – | ﹤0.01% | 2906 |
|
|
2022
Q3 | $77K | Buy |
6,015
+371
| +7% | +$4.75K | ﹤0.01% | 2886 |
|
|
2022
Q2 | $72K | Sell |
5,644
-875
| -13% | -$11.2K | ﹤0.01% | 2927 |
|
|
2022
Q1 | $68K | Hold |
6,519
| – | – | ﹤0.01% | 2946 |
|
|
2021
Q4 | $101K | Buy |
6,519
+775
| +13% | +$12K | ﹤0.01% | 2905 |
|
|
2021
Q3 | $130K | Buy |
5,744
+3,549
| +162% | +$80.3K | ﹤0.01% | 2796 |
|
|
2021
Q2 | $56K | Buy |
2,195
+840
| +62% | +$21.4K | ﹤0.01% | 2916 |
|
|
2021
Q1 | $56K | Buy |
+1,355
| New | +$56K | ﹤0.01% | 2787 |
|